-+ 0.00%
-+ 0.00%
-+ 0.00%

D. Boral Capital Maintains Buy on Immunic, Maintains $10 Price Target

Benzinga·06/05/2025 11:44:51
Listen to the news
D. Boral Capital analyst Jason Kolbert maintains Immunic (NASDAQ:IMUX) with a Buy and maintains $10 price target.